What if we cared about boob health as much as we care about boob size and boob-induced profits?

A former student of mine has been working on a breast cancer fund raising project over the summer with the organization Making Strides Against Breast Cancer. His personal goal is to raise a thousand dollars, and he asked me if I was willing to help him achieve this goal via spreading the word. Being the caring professor that I am (even though I have reputation for being “hard”) I wanted to link to his fund raising page here.*** But, being the ever-questioning-can’t-turn-the-analysis-off professor that I also am, I wanted to use this opportunity to examine breast cancer fund raising in general and the commodification of boobies via the think pink mentality.

As Jesse writes,

As far as the consumerist “think pink” mentality goes … the truth is it really was just a marketing ploy that was slapped on issues surrounding breast cancer about a decade ago and was so successful it just never really went away. The whole pink ribbon campaign and all things pink, marketed directly at women (white, middle-class, with a bunch of fund raising free time on there hands) was such a success because it took what once was such a horrifying disease and physically deforming for everyday women (because in our society one of a women’s greatest assets is her rack, don’t pay attention to her ideas or thoughts), and was able to make it something beautiful and finally shed some light on what once was a social taboo.

The truth is I do not agree with the notion that breasts are the most important feature of a women…or even that breast cancer is only a women’s issue…but I do believe that if it had not been for the “think pink” mentality attached to breast cancer awareness today…we would be nowhere near as close to finding a cure as we find ourselves today.

I think Jesse makes very valid points here – namely that while “Think Pink” has its problems, it did help to create social awareness and put breast cancer on the map. However, now that breast cancer is on the consciousness desktop of our culture, it seems maybe we could move beyond the “buy it for the boobs” mentality and into a more nuanced approach – one that would examine how toxic dumping/radioactive waste is linked to rising cancer rates (dumping done by the very same corporations that want to make a profit off you thinking they are pink), how poverty is linked to cancer rates (because guess where you get to live when you are poor – near the toxic dump sites), and how the fetishized sexualization of breasts does not translate into caring about healthy breasts, let alone healthy women.

According to Judy Brady, one of the worst offenders in what she calls “the marketing of breast cancer” is the Susan G. Komen Foundation and its annual 5K ‘Race for the Cure. As Mary Ann Swissler reports,

Now held year-round in 110 U.S. cities and abroad, the festivities offend Brady and the group Toxic Links Coalition. The races, they say, merely focus women on finding a medical cure for breast cancer, and away from environmental conditions causing it, the problems of the uninsured, and political influence of corporations over the average patient.

The Toxic Link Coalition, unlike other mainly for profit organizations, aims “to educate our communities about the links between environmental toxins and the decline in public health.” As their website reads:

Toxic Links Coalition works to stop the proliferation of chemical, radioactive, and industrial substances that threaten human health and the health of the planet. The Toxic Links Coalition believes we all have a right to health and environmental justice; views cancer and other environmentally linked diseases and disorders as human rights abuses, not as individual medical problems; targets companies that perpetrate irresponsible production, use, and disposal of carcinogenic and toxic wastes and products; demands accountability from corporate and agricultural polluters; works against environmental racism, and recognizes that people of color, immigrants, and workers bear a disproportionately high toxic burden.

TLC has renamed a public relations gimmick created and hosted by pharmaceutical and chemical giant, Zeneca, known as “Breast Cancer Awareness Month” (October), to “Cancer Industry Awareness Month.” TLC educates the public about companies with questionable ethical and environmental track records who hold a vested financial interest in maintaining the current cancer research, treatment, and prevention strategy standards.

In her excellent essay, (read the entire piece here) “Welcome to Cancerland” Barbara Ehrenreich examines this deep-seated hypocrisy of what she terms “the Cancer Industrial Complex”:

…by ignoring or underemphasizing the vexing issue of environmental causes, the breast cancer cult turns women into dupes of what could be called the Cancer Industrial Complex: the multinational corporate enterprise that with the one hand doles out carcinogens and disease and, with the other, offers expensive, semi-toxic pharmaceutical treatments. Breast Cancer Awareness Month, for example, is sponsored by AstraZeneca (the manufacturer of tamoxifen), which, until a corporate reorganization in 2000, was a leading producer of pesticides, including acetochlor, classified by the EPA as a “probable human carcinogen.” This particularly nasty conjuncture of interests led the environmentally oriented Cancer Prevention Coalition (CPC) to condemn Breast Cancer Awareness Month as “a public relations invention by a major polluter which puts women in the position of being unwitting allies of the very people who make them sick.” Although AstraZeneca no longer manufactures pesticides, CPC has continued to criticize the breast-cancer crusade — and the American Cancer Society — for its unquestioning faith in screening mammograms and careful avoidance of environmental issues. In a June 12, 2001, press release, CPC chairman Samuel S. Epstein, M.D., and the well-known physician activist Quentin Young castigated the American Cancer Society for its “longstanding track record of indifference and even hostility to cancer prevention . . . Recent examples include issuing a joint statement with the Chlorine Institute justifying the continued global use of persistent organochlorine pesticides, and also supporting the industry in trivializing dietary pesticide residues as avoidable risks of childhood cancer. ACS policies are further exemplified by allocating under 0.1 percent of its $700 million annual budget to environmental and occupational causes of cancer.

Similarly, in her article “Breast Cancer Sells,” Lucinda Marshall notes the hypocrisy of promoting people to “buy for the cure” when what they are buying is actually part of the cause:

A Pine Sol ad in Essence features motorcycle riders Aj Jemison and Jan Emanuel “driving for the cure,” which is awfully hard when your vehicle is spewing cancer-causing exhaust. On top of that, Pine Sol contains 2-butoxyethanol (EGBE), which has been linked to fertility disorders, birth defects and other medical problems.

Marshall also points out that while most women with breast cancer are over 50 and are disproportionately represented by poor women and women of color, that ads indicate breast cancer is an affliction of the young and hot. As Marshall details, a Vogue ad, featuring Ralph Lauren’s polo shirts that have bull’s eye’s above the breasts (supposedly to indicate we need to ‘target breast cancer’) “shows a group of young, mostly white women wearing skimpy thongs, the polo shirts and nothing else. Subtle, huh?” Yes, because thong underwear really hits home the seriousness of the disease.

Ads are not the only young-centric arena though. News coverage of breast cancer focuses on the young, white, and hot. As Marshall writes:

Unfortunately, while most breast cancer victims are over the age of 50, not one of the nine magazines I analyzed focused on those women and the impact the disease has on their lives. Far more typical is a piece in Vogue discussing a very attractive young woman’s agonizing choice to have a preventive double mastectomy because she carries the genes that can cause breast cancer. And with the exception of Essence, whose target audience is black, most of the women in these survivor stories are white, even though black women are more likely to die from the disease.

This links to the recent massive coverage of Christina Applegate’s breast cancer. If it were Whoopi Goldberg, or Margaret Cho, or Doris Roberts would there be as much coverage? Doubt it. Who cares about saggy boobs? Who cares about boobs of color? Not the media, that’s for sure.

In fact, as Ehrenreich’s essay reveals, we don’t approach cancer as an affliction affecting humans, but rather in a way that dehumanizes and objectifies the person with cancer. When Erhrenreich’s surgeon announced to her that “”Unfortunately, there is a cancer,” she shares that it took “all the rest of that drug-addled day to decide that the most heinous thing about that sentence is not the presence of cancer but the absence of me — for I, Barbara, do not enter into it even as a location, a geographical reference point. Where I once was — not a commanding presence perhaps but nonetheless a standard assemblage of flesh and words and gesture — “there is a cancer.” I have been replaced by it, is the surgeon’s implication. This is what I am now, medically speaking.”

As Ehrenreich’s piece conveys, her experience with breast cancer was profoundly dehumanizing and the perky think pink ads do nothing to convey the batteries of tests, the psychological and emotional ramifications, the reality that one’s body is turning against itself:

The endless exams, the bone scan to check for metastases, the high-tech heart test to see if I’m strong enough to withstand chemotherapy — all these blur the line between selfhood and thing-hood anyway, organic and inorganic, me and it. As my cancer career unfolds, I will, the helpful pamphlets explain, become a composite of the living and the dead-an implant to replace the breast, a wig to replace the hair.

Noting that breast cancer is “the biggest disease on the cultural map,” Ehrenreich shares that:

breast cancer has blossomed from wallflower to the most popular girl at the corporate charity prom. While AIDS goes begging and low-rent diseases like tuberculosis have no friends at all, breast cancer has been able to count on Revlon, Avon, Ford, Tiffany, Pier 1, Estee Lauder, Ralph Lauren, Lee Jeans, Saks Fifth Avenue, JC Penney, Boston Market, Wilson athletic gear — and I apologize to those I’ve omitted. You can “shop for the cure” during the week when Saks donates 2 percent of sales to a breast-cancer fund; “wear denim for the cure” during Lee National Denim Day, when for a $5 donation you get to wear blue jeans to work. You can even “invest for the cure,” in the Kinetics Assets Management’s new no-load Medical Fund, which specializes entirely in businesses involved in cancer research.

Her characterization of breast cancer as a popular girl at the prom seems particularly fitting given that the whole think pink culture is gendered in the extreme. From teddy bears to bubblegum pink lipgloss, breast cancer culture wraps the disease not only in buying for the cure, but also in the infantalization of women with breast cancer. As if declining boob health led to a reversion back to childhood, breast cancer cards, gifts, websites, etc. abound in girly images decked out in baby pink. As Ehrenreich details,

A tote bag distributed to breast cancer patients by the Libby Ross Foundation (through places such as the Columbia Presbyterian Medical Center) contains, among other items, a tube of Estee Lauder Perfumed Body Crème, a hot-pink satin pillowcase, an audiotape “Meditation to Help You with Chemotherapy,” a small tin of peppermint pastilles, a set of three small inexpensive rhinestone bracelets, a pink-striped “journal and sketch book,” and — somewhat jarringly — a small box of crayons.

As she quips, “Certainly men diagnosed with prostate cancer do not receive gifts of Matchbox cars.” No, and can you imagine anything close to similar if we had a testicular cancer culture? Of course not, because this culture would never exist in the first place – men’s bodies (and their parts) are coded as private. No “think prostate” campaigns with accompanying Bermuda shorts designed by Ralph Lauren with arrows pointing to the male genital region are forthcoming I am quite sure… No, because commodifying the male body is not the norm. This is exactly why we have embraced a think pink breast cancer culture while no such fluffy, makeover/survivor narratives accompany AIDS, tuberculosis, or that boringly prosaic killer of millions, malnutrition. It’s do much easier to package breasts in feel good pink and to market ‘cures’ to that part of the populace that has already been taught the “I shop, therefore I am” mantra from birth.

Furthermore, breast cancer can “sell” partly because it is based on a product that is so popular – BOOBIES! As breast shaped cakes, cupcake pans, lamps, pencil sharpeners, etc. attest, breasts sell (see some sample ‘breast products’ here). However, the phallus and its testicular sidekicks are not near as marketable. Nor, as this story from Jesse attests, are the penis/balls allowed to be put on public display and commodified in the same way as breasts:

In high school I started a cancer awareness club on campus, and during prostate cancer awareness month I wanted to host an event to promote awareness and encourage young men to get themselves checked. What I proposed to my club was that we print out a bunch of little pieces of paper that read “get yourself checked. prostate cancer” and tie each piece to little sacks with gumballs inside to look like male genitalia. It made sense to me, I mean we gave out cupcakes with boobs on top for breast cancer awareness month and no one seemed to have a problem with it! But, to my surprise everyone voted not to do it. That was the first time I think I ever came face to face with sexism in cancer awareness.

Sexism in cancer awareness indeed! Seems part of this “awareness” is making the populace buy into the belief that boobs are a REALLY important part of being female, and that being female involves loving pink jewelry, make up, and teddy bears – of, in short, being infantalized and sexualized and objectified all while wrapped in a pretty pink bow.

Yet, in spite of the commodification of breast cancer, and the huge boob induced profits raked in by corporations that poison water and earth with one hand while hawking pink products with the other, there is of course still a desperate need to care about boob health. And, for now, those doing the most productive caring, if you ask me, are feminists. As Ehrenreich shares, “Like everyone else in the breast-cancer world, the feminists want a cure, but they even more ardently demand to know the cause or causes of the disease without which we will never have any means of prevention.”

However, mainstream pink boob culture perpetuates narratives about ‘bad genes’ and ‘risk factors,’ even though such genes account for fewer than 10 percent of breast cancers and only 30 percent of women diagnosed with breast cancer have known risk factors. As Ehrenreich relates:

suspicion should focus on environmental carcinogens… such as plastics, pesticides (DDT and PCBs, for example, though banned in this country, are still used in many Third World sources of the produce we eat), and the industrial runoff in our ground water. No carcinogen has been linked definitely to human breast cancer yet, but many have been found to cause the disease in mice, and the inexorable increase of the disease in industrialized nations — about one percent a year between the 1950s and the 1990s — further hints at environmental factors, as does the fact that women migrants to industrialized countries quickly develop the same breast-cancer rates as those who are native born. Their (feminists) emphasis on possible ecological factors, which is not shared by groups such as Komen and the American Cancer Society, puts the feminist breast-cancer activists in league with other, frequently rambunctious, social movements — environmental and anticorporate.

Aaawww, but it wouldn’t be near as fun to “race for the cure” if that race involved feminist activism instead of cute little bears in pink tutus. It wouldn’t be as uplifting to focus on the ways in which the toxicity of our environment along with institutionalized poverty and lack of adequate clean drinking water (let alone adequate healthcare) mitigate the possibility of healthy boobs (or a healthy body). It’s far more fun, if less effective, to come up with zippy slogans and cute pink products all in the name of big boob profits. Because who really cares about boob health when unhealthy boobs create ballooning triple D boob induced profits?

To close, I know someone who does care about boob profits, and he is the person who prompted me to write this post. A tireless crusader against cancer, he is well aware of the problems with the think pink mentality. However, as he writes, “I do these walks and fundraise my ass off, because in a society that views breast cancer as cute pink ribbons and bears in pink tutu’s…what is a boy to do? My hope is that one day people will tear away from the think pink mentality of breast cancer and instead focus on the disease itself.” I am right there along with you hoping. Jesse.

***http://main.acsevents.org/goto/jesseburns

Jessie notes that “As for any questions anyone may have for the events disbursement of the funds raised…I have all the answers. Making Strides Against Breast Cancer is an American Cancer Society event and as such the money is divided up 3 ways: 82% goes completely back to cancer research and clinical studies, 14% goes to putting on the event (rentals, fees, supplies), and only 4% goes back to administrative costs (staff payroll).”

Advertisements

13 thoughts on “What if we cared about boob health as much as we care about boob size and boob-induced profits?”

  1. This is by far my favorite post prof. perhaps because it was in large part inspired my none other than…myself! ha ha 🙂
    I have to point out my favorite point made here. Barbara Ehrenreich! Her experience with cancer as an industry is truely eye opening and probably one of the most informative pieces i have ever read…ever!
    With that said I think you pretty much summed up everything perfectly in saying “now that breast cancer is on the consciousness desktop of our culture, it seems maybe we could move beyond the ‘buy it for the boobs’ mentality and into a more nuanced approach”.

  2. Fascinating post – as always. I have felt uneasy about the focus on breast cancer but could not really figure it until now.
    In my country, Scotland, more women die of lung cancer than of breast cancer, but there is not a sense that lung cancer is a woman’s issue, nor is it a cancer to fundraise for in anything like the same way. It’s somehow not as glamorous or as easily commercialised. Your post helps me understand that a bit more.

  3. While I agree with many of your points… well, to a point. There are a few things I would like to point out.the Race for the Cure is a local Komen event, put on to fund local grants. I think 25% goes to the national research foundation. Where does the other money go? To other the other local breast cancer non profits, to fund programs for low cost mammograms, genetic testing for those who can’t afford it, patient navigator programs, prevention education, survivors support.

    Too many people confuse the national mission of funding research with that is done on the local level…

    “The races, they say, merely focus women on finding a medical cure for breast cancer, and away from environmental conditions causing it, the problems of the uninsured, and political influence of corporations over the average patient.”

    trying to give as many people access to the same quality care is what Komen does on a local level.

    However, ACS is hardly an organization to work for…

    http://www.preventcancer.com/losing/acs/wealthiest_links.htm

    Thus for every $1 spent on direct service, approximately $6.40 is spent on compensation and overhead. In all ten states, salaries and fringe benefits are by far the largest single budget items, a surprising fact in light of the characterization of the appeals, which stress an urgent and critical need for donations to provide cancer services.

    Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication.

    Most of the funds raised by the ACS go to pay overhead, salaries, fringe benefits, and travel expenses of its national executives in Atlanta. They also go to pay chief executive officers, who earn six-figure salaries in several states, and the hundreds of other employees who work out of some 3,000 regional offices nationwide. The typical ACS affiliate, which helps raise the money for the national office, spends more than 52 percent of its budget on salaries, pensions, fringe benefits, and overhead for its own employees. Salaries and overhead for most ACS affiliates also exceeded 50 percent, although most direct community services are handled by unpaid volunteers. DiLorenzo summed up his findings by emphasizing the hoarding of funds by the ACS (4):

    Not that I believe Komen is all good and ACS is all bad, but I’d reather have my local fundraising dollars actually going to programs that help the community.

  4. Jesse,
    Glad you approve of the post! Yes, Ehrenreich’s piece is great.

    VegAnne,
    Thanks very much for reading and commenting. Interesting to hear that although more women die of lung cancer in Scotland, it has not been commercialized in the way breast cancer has. Guess lungs don’t sell as well as breasts!

    Courtney,
    Thanks much for reading and for the detailed discussion of fund raising. You raise some really key points. I was especially taken aback by the following:
    “Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication.” How disheartening. Your mention of the six figure salary of fund raising execs also gets my goat. As you suggest, it seems a smaller, more localized approach to fund raising would be better — rather than the corporatized fund raising that seems to be the norm now.

    Feminist Law Profs,
    Thanks for the pingback! I do like being “provocative.”

  5. Thank you for this excellent discussion of the use of breast cancer as a marketing ploy. I want to also let your readers know that the Feminist Peace Network blog, http://www.feministpeacenetwork.org regularly covers this subject–most recently BMW’s campaign offering to donate a dollar to breast cancer research for every test drive taken, nevermind that auto exhaust is a carcinogen. We will once again have extensive coverage of the subject during National Breast Cancer Awareness Month in October.

  6. Lucinda,
    Thanks! And thank you for alerting me to Feminist Peace Network’s regular coverage of this topic.

  7. This is a really great post. I have in the past written about certain BC campaigns taking the tonw that we should care b/c we like breasts, not because women’s lives are a risk, but I’ve done no more on it. Thanks so much for this comprehensive post!

  8. Please let me know if you’re looking for a author for your blog. You have some really great articles and I feel I would be a good asset. If you ever want to take some of the load off, I’d love
    to write some articles for your blog in exchange for a link back to mine.
    Please send me an email if interested. Thanks!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s